UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intranasal respiratory syncytial virus vaccine attenuated by codon-pair deoptimization of seven open reading frames is genetically stable and elicits mucosal and systemic immunity and protection against challenge virus replication in hamsters

PLoS pathogens, 2024-05, Vol.20 (5), p.e1012198-e1012198

2024

Volltextzugriff (PDF)

Immunological Lessons from Respiratory Syncytial Virus Vaccine Development

Immunity (Cambridge, Mass.), 2019-09, Vol.51 (3), p.429-442

2019

Volltextzugriff (PDF)

Respiratory syncytial virus infection and novel interventions

Nature reviews. Microbiology, 2023-11, Vol.21 (11), p.734-749

2023

Volltextzugriff (PDF)

Viral N 6 -methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus

Nature communications, 2019-10, Vol.10 (1), p.4595-18

2019

Volltextzugriff (PDF)

Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies

PloS one, 2014, Vol.9 (6), p.e100392

2014

Volltextzugriff (PDF)

Long-Term SARS-CoV-2 Findings Related to Persisting Viral Antigen and Inflammation Resemble Those Reported for Influenza Virus and Respiratory Syncytial Virus

Viruses, 2024-09, Vol.16 (9), p.1353

Roberts, Jr, Norbert J

2024

Volltextzugriff (PDF)

An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults

The Journal of infectious diseases, 2017-12, Vol.216 (11), p.1362-1370

2017

Volltextzugriff (PDF)

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

Nature (London), 2013-09, Vol.501 (7467), p.439-443

2013

Volltextzugriff (PDF)

A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice

Vaccine, 2017-02, Vol.35 (5), p.757-766

2017

Volltextzugriff (PDF)

Immunopathology of RSV: An Updated Review

Viruses, 2021-12, Vol.13 (12), p.2478

2021

Volltextzugriff (PDF)

Investigational RSV Vaccine Given During Pregnancy Protects Newborns

JAMA : the journal of the American Medical Association, 2022-12, Vol.328 (22), p.2201

Larkin, Howard

2022

Volltextzugriff (PDF)

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation

Nature communications, 2016-12, Vol.7 (1), p.13916-12, Article 13916

2016

Volltextzugriff (PDF)

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease

Virology (New York, N.Y.), 2016-07, Vol.494, p.215-224

2016

Volltextzugriff (PDF)

Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants

Vaccine, 2020-01, Vol.38 (2), p.251-257

2020

Volltextzugriff (PDF)

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant

The Journal of infectious diseases, 2017-01, Vol.215 (1), p.24-33

2017

Volltextzugriff (PDF)

Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model

Nature communications, 2018-05, Vol.9 (1), p.1904-10, Article 1904

2018

Volltextzugriff (PDF)

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

Vaccine, 2024-05, Vol.42 (15), p.3474-3485

2024

Volltextzugriff (PDF)

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Immunity (Cambridge, Mass.), 2021-04, Vol.54 (4), p.769-780.e6

2021

Volltextzugriff (PDF)

Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting

PloS one, 2015-09, Vol.10 (9), p.e0138018-e0138018

2015

Volltextzugriff (PDF)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B

PloS one, 2017-04, Vol.12 (4), p.e0175792-e0175792

2017

Volltextzugriff (PDF)

A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models

PloS one, 2015-03, Vol.10 (3), p.e0119509-e0119509

2015

Volltextzugriff (PDF)

Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG

Proceedings of the National Academy of Sciences - PNAS, 2008-12, Vol.105 (52), p.20822-20827

2008

Volltextzugriff (PDF)

Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age

PloS one, 2013, Vol.8 (10), p.e77104

2013

Volltextzugriff (PDF)

RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection

Nature communications, 2015-12, Vol.6 (1), p.10224, Article 10224

2015

Volltextzugriff (PDF)

Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants

Vaccine, 2024-11, Vol.42 (25), p.126119, Article 126119

2024

Volltextzugriff (PDF)

1 – 25 von 1.555

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

ThemaViruses

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.502)
Mit Volltextzugriff
(1.363)

Publikationsform

Sprache

Englisch
(1.552)
Türkisch
(2)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

Intranasal respiratory syncytial virus vaccine attenuated by codon-pair deoptimization of seven open reading frames is genetically stable and elicits mucosal and systemic immunity and protection against challenge virus replication in hamsters

Immunological Lessons from Respiratory Syncytial Virus Vaccine Development

Respiratory syncytial virus infection and novel interventions

Viral N 6 -methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus

Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies

Long-Term SARS-CoV-2 Findings Related to Persisting Viral Antigen and Inflammation Resemble Those Reported for Influenza Virus and Respiratory Syncytial Virus

An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice

Immunopathology of RSV: An Updated Review

Investigational RSV Vaccine Given During Pregnancy Protects Newborns

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease

Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant

Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B

A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models

Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG

Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age

RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection

Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants

Aktive Filter

Suchergebnisse filtern